Union Health Minister Mansukh Mandaviya provided insights into the evolving nature of the COVID-19 virus and India’s role in global healthcare in the Lok Sabha on Friday. Mandaviya highlighted that the virus has mutated 223 times worldwide, leading to a significant reduction in its harmful effects over time.
During the Question Hour, Mandaviya emphasized that while COVID-19 will persist, its current variants are not as deadly as earlier strains. Drawing a parallel with influenza, he stated that COVID-19 is likely to remain endemic and manageable, akin to the seasonal flu.
The minister stressed the importance of international collaboration in tackling health challenges, noting the positive outcomes achieved through global cooperation during the pandemic. He underscored India’s robust pharmaceutical industry, pointing out that the country now produces 70% of the world’s HIV/AIDS medicines and various other essential drugs.
Speaker Om Birla echoed Mandaviya’s sentiments, sharing his observations of the high demand for Indian medicines during his travels in Africa.
Mandaviya also highlighted the impact of India’s healthcare initiatives, citing the Ayushman Bharat scheme, which provides free medical treatment to millions living below the poverty line. He noted that 13 crore individuals have benefited from the scheme, lifting them out of poverty by alleviating the financial burden of medical expenses.
Comparing the current government’s healthcare expenditure to its predecessor, Mandaviya revealed an increase in spending from 1.13% to 1.35% of GDP, demonstrating a commitment to strengthening India’s healthcare infrastructure.
